On the recordMarch 14, 2016
We are looking for guidance from the FDA on this, and this is an issue that we are very concerned with because again it has to do with patient care.
Source
congress.govWe are looking for guidance from the FDA on this, and this is an issue that we are very concerned with because again it has to do with patient care.
Carter emphasizes the need for FDA guidance on compounded medications for patient care.
Share & report
More from Buddy Carter
In the first two years of the Biden Administration, this government has spent over $500 billion in improper payments.
We all want the same things. Republicans and Democrats want the same thing. We want affordability, accessibility. We want quality in healthcare.